Evidence map›Paper›PMID 41612897›Full record

ReviewJournal of peptide science : an official publication of the European Peptide Society2026

Making Blank Faces Expressive: Chemical Approaches to the Modification of Chemically Inert Peptides.

Yoshitaka Moriyama, Hikari Sada, Takeshi Nanjo

Abstract readReview
In one paragraph

Review in Journal of peptide science : an official publication of the European Peptide Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Making Blank Faces Expressive: Chemical Approaches to the Modification of Chemically Inert Peptides.Journal of peptide science : an official publication of the European Peptide Society · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yoshitaka MoriyamaGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Hikari SadaGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Takeshi NanjoGraduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.ORCID https://orcid.org/0000-0002-5679-6701

Funding

Japan Society for the Promotion of Science JP22H02743Japan Society for the Promotion of Science JP23K24006JST SPRING JPMJSP2110
6 · The paper itself

Abstract

Very minor structural modifications in peptides can result in significant changes in their function. To obtain analogues with such small structural but big functional differences compared to the original peptides, amino acid monomers are usually combined one-by-one from scratch, which is a simple and reliable but painfully laborious strategy. One alternative and very fascinating approach is the chemical modification of existing peptides, which allows for the rapid production of derivatives with fewer synthetic steps. However, such approaches generally target the reactive functional groups in cysteine and lysine residues, particularly in the case of larger peptides, and the modification of peptides that do not feature these functionalities is more difficult. Nevertheless, chemists have also been exploring methods that can be applied even to such chemically inert peptides based on recent advances in C-H activation and hydrogen atom transfer (HAT) chemistry. If successful, these strategies would represent a breakthrough in terms of obtaining unusual peptide structures in a time- and cost-effective manner. This review focuses on recent attempts to achieve such ambitious chemical modifications, albeit that these are currently limited to relatively small peptides.

Indexed as

PeptidesCatalysisHydrogenMolecular StructureHydrogenPeptideschemical modificationC–H functionalizationmetal catalysispeptideradicals

Identifiers

PMID41612897
PMCPMC12856538

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.